Alfred P. Wolf

Alfred P. Wolf's AcademicInfluence.com Rankings

Alfred P. Wolf

Chemistry

#2183

World Rank

#3054

Historical Rank

Chemical Engineering

#185

World Rank

#199

Historical Rank

chemistry Degrees

Download Badge

Chemistry

Alfred P. Wolf's Degrees

PhD Chemical Engineering Stanford University

Why Is Alfred P. Wolf Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Alfred P. Wolf's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Graphical Analysis of Reversible Radioligand Binding from Time—Activity Measurements Applied to [N-11C-Methyl]-(−)-Cocaine PET Studies in Human Subjects (1990) (1398)
Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers (1993) (905)
Metabolic trapping as a principle of oradiopharmaceutical design: some factors resposible for the biodistribution of [18F] 2-deoxy-2-fluoro-D-glucose. (1978) (606)
A FLUORINATED GLUCOSE ANALOG, 2‐FLUORO-2‐DEOXY-D‐GLUCOSE (F‐18): NONTOXIC TRACER FOR RAPID TUMOR DETECTION (1980) (562)
Changes in brain glucose metabolism in cocaine dependence and withdrawal. (1991) (448)
Negative symptoms and hypofrontality in chronic schizophrenia. (1992) (417)
Effects of chronic cocaine abuse on postsynaptic dopamine receptors. (1990) (413)
Long‐Term frontal brain metabolic changes in cocaine abusers (1992) (412)
Labeled 2-deoxy-D-glucose analogs. 18F-labeled 2-deoxy-2-fluoro-D-glucose, 2-deoxy-2-fluoro-D-mannose and 14C-2-deoxy-2-fluoro-D-glucose (1978) (410)
Imaging endogenous dopamine competition with [11C]raclopride in the human brain (1994) (391)
Mapping human brain monoamine oxidase A and B with 11C-labeled suicide inactivators and PET. (1987) (351)
Brain monoamine oxidase A inhibition in cigarette smokers. (1996) (331)
Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography. (1985) (306)
Mapping cocaine binding sites in human and baboon brain in vivo (1989) (303)
Striatal binding of the PET ligand 11C‐raclopride is altered by drugs that modify synaptic dopamine levels (1993) (299)
Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain. (1982) (285)
Dopamine blockade and clinical response: evidence for two biological subgroups of schizophrenia. (1989) (261)
Regional brain glucose metabolism in chronic schizophrenia. A positron emission transaxial tomographic study. (1984) (236)
Radiopharmaceuticals XXVII. 18F-labeled 2-deoxy-2-fluoro-d-glucose as a radiopharmaceutical for measuring regional myocardial glucose metabolism in vivo: tissue distribution and imaging studies in animals. (1977) (233)
Phenomenological correlates of metabolic activity in 18 patients with chronic schizophrenia. (1987) (231)
Computed Tomography and Positron Emission Transaxial Tomography Evaluations of Normal Aging and Alzheimer's Disease (1983) (207)
Increased accumulation of 2-deoxy-2-[18F]Fluoro-D-glucose in liver metastases from colon carcinoma. (1982) (206)
Recovery of brain glucose metabolism in detoxified alcoholics. (1994) (186)
Acute effects of ethanol on regional brain glucose metabolism and transport (1990) (183)
Positron Emission Tomography in the Study of Aging and Senile Dementia (1980) (175)
Positron emission tomographic studies of aging and Alzheimer disease. (1983) (175)
Decreased brain metabolism in neurologically intact healthy alcoholics. (1992) (167)
Absolute Cross Sections for the Production of 18F via the 18O(p, n)18F Reaction (1979) (156)
The production of ultra high activity 11C-labeled hydrogen cyanide, carbon dioxide, carbon monoxide and methane via the reaction (XV) (1975) (154)
Slow recovery of human brain MAO B after L‐Deprenyl (Selegeline) withdrawal (1994) (150)
Working Against Time: Rapid Radiotracer Synthesis and Imaging the Human Brain (1997) (145)
Measuring age-related changes in dopamine D2 receptors with 11C-raclopride and 18F-N-methylspiroperidol (1996) (141)
Detection of DNA synthesis in intact organisms with positron-emitting (methyl- 11 C)thymidine. (1972) (139)
Serial [18F]N-methylspiroperidol PET studies to measure changes in antipsychotic drug D-2 receptor occupancy in schizophrenic patients (1988) (139)
Brain metabolism in patients with schizophrenia before and after acute neuroleptic administration. (1986) (133)
Anhydrous F-18 labeled eslemental flurine for radiopharmaceutical preparation. (1980) (131)
Turnover of Brain Monoamine Oxidase Measured In Vivo by Positron Emission Tomography Using l‐[11C]Deprenyl (1987) (130)
Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal human subjects. (1993) (127)
The radiation dosimetry of 2 [F-18]fluoro-2-deoxy-D-glucose in man. (1982) (125)
Decreased cerebral response to inhibitory neurotransmission in alcoholics. (1993) (117)
Neuropharmacological actions of cigarette smoke: brain monoamine oxidase B (MAO B) inhibition. (1998) (116)
Mapping muscarinic receptors in human and baboon brain using [N‐11C‐methyl]‐benztropine (1990) (112)
A new improved synthesis of 2-deoxy-2-[18F]fluoro-d-glucose from 18F-labeled acetyl hypofluorite. (1982) (110)
Dopamine receptor occupancy and plasma haloperidol levels. (1989) (106)
Effects of endogenous dopamine on measures of [18F]N‐methylspiroperidol binding in the basal ganglia: Comparison of simulations and experimental results from PET studies in baboons (1991) (106)
Effects of haloperidol challenge on regional cerebral glucose utilization in normal human subjects. (1994) (103)
Comparison of Three 18F‐Labeled Butyrophenone Neuroleptic Drugs in the Baboon Using Positron Emission Tomography (1985) (102)
Positron Emission Tomography and Computed Tomography Assessments of the Aging Human Brain (1984) (99)
Brain Organization in Schizophrenia (1986) (98)
[18F]-N-Methylspiroperidol: the radioligand of choice for PETT studies of the dopamine receptor in human brain. (1985) (96)
Regional brain metabolic response to lorazepam in subjects at risk for alcoholism. (1995) (96)
Amphetamine induced decreases in (18F)‐N‐methylspiroperidol binding in the baboon brain using positron emission tomography (PET) (1991) (96)
Intersubject variability of brain glucose metabolic measurements in young normal males. (1994) (92)
Depression of Thalamic Metabolism by Lorazepam Is Associated with Sleepiness (1995) (89)
Astatine-211--tellurium radiocolloid cures experimental malignant ascites. (1981) (82)
A shielded synthesis system for production of 2-deoxy-2-[18F]fluoro-D-glucose. (1981) (79)
Separation of [18F]fluoride from [18O]water using anion exchange resin. (1990) (79)
Monoamine oxidase B (MAO B) inhibitor therapy in Parkinson's disease (1993) (79)
Improved delineation of human dopamine receptors using [18F]-N-methylspiroperidol and PET. (1986) (77)
Syntheses and Specific Activity Determinations of No-Carrier-Added Fluorine-18-Labeled Neuroleptic Drugs (1985) (77)
211At radiocolloid therapy: further observations and comparison with radiocolloids of 32P, 165Dy, and 90Y. (1984) (77)
Positron emission tomography studies of normal aging: A replication of PET III and 18-FDG using PET VI and 11-CDG (1987) (76)
Evaluation of age-related changes in serotonin 5-HT2 and dopamine D2 receptor availability in healthy human subjects. (1995) (75)
[11C]spiroperidol: synthesis, specific activity determination, and biodistribution in mice. (1982) (75)
Pharmacokinetics and in vivo specificity of [LLC]dl‐threo‐methylphenidate for the presynaptic dopaminergic neuron (1994) (74)
18F-2-deoxy-2-fluoro-D-glucose as a tracer in the positron emission tomographic study of senile dementia. (1982) (74)
Patterns of metabolic activity in the treatment of schizophrenia (1984) (73)
The synthesis of 18 F-5-fluorouracil. VII. (1973) (72)
Importance of pharmacologic control in PET studies: Effects of thiothixene and haloperidol on cerebral glucose utilization in chronic schizophrenia (1991) (70)
Crystal and molecular structures of methoxytetraphenylantimony and dimethoxytriphenylantimony (1968) (69)
The Chemistry of Positron Emitting Nucleogenic (Hot) Atoms with Regard to Preparation of Labelled Compounds of Practical Utility (1983) (68)
No-carrier-added fluorine-18-labeled N-methylspiroperidol: synthesis and biodistribution in mice. (1986) (67)
The Biosynthesis of Nicotine from Isotopically Labeled Nicotinic Acids1 (1960) (66)
Cyclotron isotopes and radiopharmaceuticals—XXIII (1978) (66)
Carbon-11 and radiopharmaceuticals. (1977) (66)
Distribution and kinetics of carbon-11-cocaine in the human body measured with PET. (1992) (66)
Low cerebellar metabolism in medicated patients with chronic schizophrenia. (1992) (65)
A comparison of technetium 99M and iodine 123 for thyroid imaging. (1973) (65)
Labeled putrescine as a probe in brain tumors. (1983) (64)
Abnormal Temporal Lobe Response in Alzheimer's Disease during Cognitive Processing as Measured by 11C-2-Deoxy-D-Glucose and PET (1987) (64)
Labeled aryl fluorides from the nucleophilic displacement of activated nitro groups by 18F‐F− (1983) (64)
Selective, irreversible in vivo binding of [11C]clorgyline and [11C]-L-deprenyl in mice: potential for measurement of functional monoamine oxidase activity in brain using positron emission tomography. (1985) (62)
The in vitro radiobiology of astatine-211 decay. (1986) (62)
Quantitative autoradiography with radiopharmaceuticals, Part 2: Applications in radiopharmaceutical research: concise communication. (1983) (61)
A synthesis of 2-deoxy-D-[1-11C]glucose for regional metabolic studies: concise communication. (1981) (61)
Synthesis of suicide inhibitors of monoamine oxidase: Carbon‐11 labeled clorgyline, L‐deprenyl and D‐deprenyl (1988) (59)
Organic radiopharmaceuticals labeled with isotopes of short half-life. V. 18 F-labeled 5- and 6-fluorotryptophan. (1972) (58)
Iodine-123 production for radiopharmaceuticals--XX excitation functions of the 124Te(p, 2n)123I and 124Te(p, n)124I reactions and the effect of target enrichment on radionuclidic purity. (1977) (57)
Carbon-11 labeled aliphatic amines in lung uptake and metabolism studies: potential for dynamic measurements in vivo. (1976) (56)
Positron emission tomography (PET) studies of dopaminergic/cholinergic interaction in the baboon brain (1990) (54)
Plasma input function determination for PET using a commercial laboratory robot. (1995) (53)
Synthesis of high specific activity (+)- and (-)-6-[18F]fluoronorepinephrine via the nucleophilic aromatic substitution reaction. (1991) (52)
Regional correlation of PET and CT in senile dementia of the Alzheimer type. (1983) (52)
Synthesis of high specific activity 6-[18F]fluorodopamine for positron emission tomography studies of sympathetic nervous tissue. (1991) (52)
Rates of reaction of hydrogen atoms with silane and germane (1975) (50)
Cyclotrons for Biomedical Radioisotope Production (1983) (50)
Nucleophilic aromatic substitution of activated cationic groups by 18F-labeled fluoride. A useful route to no-carrier-added (NCA) 18F-labeled aryl fluorides (1985) (50)
Studies on the Mechanism of Olefin-Alcohol Interconversion. The Effect of Acidity on the O 18 Exchange and Dehydration Rates of t-Alcohols (1960) (50)
Special characteristics and potential for radiopharmaceuticals for positron emission tomography. (1981) (49)
Application of the nucleophilic substitution reaction to the synthesis of No‐carrier‐added [18F]fluorobenzene and other 18F‐labeled aryl fluorides (1984) (48)
Brain interactions in chronic schizophrenics under resting and activation conditions (1988) (48)
Quantitation of the human basal ganglia with positron emission tomography: a phantom study of the effect of contrast and axial positioning. (1991) (48)
Comparison of two pet radioligands for imaging extrastriatal dopamine transporters in human brain. (1995) (47)
Cyclotron Isotopes and Radiopharmaceuticals (1984) (46)
Synthesis of 18F‐labelled N‐(p‐[18F]fluorophenyl)maleimide and its derivatives for labelling monoclonal antibody with 18F (1989) (46)
Displacement of a nitro-group by [18F] fluoride ion. A new route to aryl flurides of high specific activity (1983) (46)
Comparison of high specific activity (-) and (+)-6-[18F]fluoronorepinephrine and 6-[18F]fluorodopamine in baboons: heart uptake, metabolism and the effect of desipramine. (1993) (44)
Brain interactions in chronic schizophrenics under resting and activation conditions (1988) (44)
THE EFFECT OF TARGET-GAS PURITY ON THE CHEMICAL FORM OF 18F DURING 18F-F2 PRODUCTION USING THE NEON/FLUORINE TARGET (1980) (44)
Ion chromatographic analysis of high specific activity 18FDG preparations and detection of the chemical impurity 2-deoxy-2-chloro-D-glucose. (1992) (44)
A rapid synthesis of 2-deoxy-2-fluoro-d-glucose from xenon difluoride suitable for labelling with 18F (1983) (42)
Synthesis of carbon-11, fluorine-18, and nitrogen-13 labeled radiotracers for biomedical applications. Nuclear Science Series: Nuclear Medicine (1982) (42)
Preparation of high-purity carrier-free 123 I-iodine monochloride as iodination reagent for synthesis of radiopharmaceuticals. IV. (1972) (40)
Acute d-amphetamine challenge in schizophrenia: Effects on cerebral glucose utilization and clinical symptomatology (1994) (40)
Regional distribution and kinetics of haloperidol binding in human brain: A pet study with [18F]haloperidol (1992) (40)
Positron emission tomography in dementia. (1983) (40)
Blunted change in cerebral glucose utilization after haloperidol treatment in schizophrenic patients with prominent negative symptoms. (1996) (39)
Organic radiopharmaceuticals labeled with short-lived nuclides. 3. 18F-labeled phenylalanines. (1971) (39)
Impurities in the [18O]water target and their effect on the yield of an aromatic displacement reaction with [18F]fluoride. (1993) (39)
Effects of amphetamine on local cerebral metabolism in normal and schizophrenic subjects as determined by positron emission tomography (2004) (38)
Correlations between glucose metabolic rates in brain regions of healthy male adults at rest and during language stimulation (1987) (38)
Serial PET studies of human cerebral malignancy with [1-11C]putrescine and [1-11C]2-deoxy-D-glucose. (1987) (38)
Syntheses of no-carrier-added (NCA) [18F]fluoroalkyl halides and their application in the syntheses of [18F]fluoroalkyl derivatives of neurotransmitter receptor active compounds (1987) (37)
Comparative PET studies of the kinetics and distribution of cocaine and cocaethylene in baboon brain (1992) (35)
Labeling of Organic Compounds by Recoil Methods (1960) (35)
Opioid receptor imaging and displacement studies with [6-O-[11C] methyl]buprenorphine in baboon brain. (1996) (35)
Positron Emission Tomography in Oncology (1988) (35)
Cyclotron isotopes and radiopharmaceuticals--XXII. Improved targetry and radiochemistry for production of 123I and 124I. (1977) (35)
Substrate selectivity and orientation in aromatic substitution by molecular fluorine (1978) (35)
Synthesis of (R)-(-)- and (S)-(+)-4-fluorodeprenyl and (R)-(-)- and (S)-(+)-[N-11C-methyl]-4-fluorodeprenyl and positron emission tomography studies in baboon brain. (1990) (35)
Stability of resting deoxyglucose metabolic values in PET studies of schizophrenia (1991) (34)
Carbon-11 labelled ketamine-synthesis, distribution in mice and PET studies in baboons. (1997) (34)
Distribution of 18F-5-fluorouracil in tumor-bearing mice and rats. (1978) (34)
Specific Binding of [11C]Spiroperidol in Rat Brain In Vivo (1983) (34)
Iodine-124 production: excitation function for the 124Te(d,2n)124I and 124Te(d,3n)123I reactions from 7 to 24 MeV (1993) (34)
A general method of tritium labeling utilizing microwave discharge activation of tritium gas. Methodology and application to biological compounds. (1973) (33)
Altered glucose metabolism in microvessels from patients with Alzheimer's disease (1989) (33)
Experimentally Determined Thick Target Yields for the 14N (ρ,α)11C Reaction (1980) (33)
Radiopharmaceuticals. 12. A new rapid synthesis of carbon-11 labeled norepinephrine hydrochloride. (1974) (32)
Studies with Differentially Labeled [11C]Cocaine, [11C]Norcocaine, [11C]Benzoylecgonine, and [11C]‐and 4′‐[18F]Fluorococaine to Probe the Extent to Which [11C]Cocaine Metabolites Contribute to PET Images of the Baboon Brain (1994) (32)
Fluorination with F/sub 2/. A convenient synthesis of 2-deoxy-2-fluoro-D-glucose (1977) (32)
Human primary visual cortex topography imaged via positron tomography (1984) (31)
Quantitative autoradiography of cocaine binding sites in human brain postmortem (1992) (31)
Scintigraphy with positron-emitting compounds.--I. Carbon-11 labeled thymidine and thymidylate. (1978) (30)
11C-labeled octanal and benzaldehyde† (1979) (30)
2-Deoxy-2-[18F]fluoro-D-glucose for metabolic studies: current status. (1986) (30)
Pet studies of cocaine inhibition of myocardial norepinephrine uptake (1994) (30)
Recovery of [18F]fluoride from [18O]water in an electrochemical cell. (1989) (30)
Synthesis and PET studies of fluorine-18-BMY 14802: a potential antipsychotic drug. (1993) (29)
The synthesis of no-carrier-added DL-4-[18F]fluorodeprenyl via the nucleophilic aromatic substitution reaction. (1991) (29)
Gas‐liquid chromatographic determination of relative amounts of 2‐deoxy‐2‐flouro‐D‐glucose and 2‐deoxy‐2‐fluoro‐D‐mannose synthesized from various methods (1985) (29)
Labelling of fluorinated aromatics by isotopic exchange with [18F]fluoride (1981) (29)
THE REARRANGEMENT OF DIPHENYL (1963) (28)
On the Probable Intermediacy of Thetrahedrane (1970) (28)
Metal isotopes used as radioactive indicators of ocular melanoma. (1977) (28)
Cyclotron isotopes and radiopharmaceuticals— XXV An anhydrous 18F-fluorinating intermediate: Trifluoromethyl hypofluorite☆ (1978) (27)
The syntheses of 1‐[11C]‐D‐glucose and related compounds for the measurement of brain glucose metabolism (1985) (27)
Electrophilic radiofluorination of aryltrimethylsilanes as a general route to 18F-labeled aryl fluorides (1985) (27)
Organic radiopharmaceuticals labeled with isotopes of short half-life. I. 11C-1-dopamine hydrochloride. (1970) (27)
Organoastatine chemistry. Astatination via electrophilic destannylation. (1986) (27)
Chapter 29. New Directions in Positron Emission Tomography (1989) (27)
Mapping brain neuroleptic receptors in the live baboon. (1984) (26)
New window flow proportional counter for counting radioactive gas-liquid partition chromatography effluents (1967) (26)
Effect of radiation on the reactions of recoil carbon-11 in the nitrogen-oxygen system (1968) (25)
Cyclotron isotopes and radiopharmaceuticals--XXX. Aspects of production, elution and automation of 81Rb-81Kr generators. (1980) (25)
Charged particle penetration in gas targets designed for accelerator production of radionuclides used in nuclear medicine (1984) (25)
Synthesis of carbon-11 labeled iodinated cocaine derivatives and their distribution in baboon brain measured using positron emission tomography. (1992) (24)
Synthesis and biodistribution of no-carrier-added [1-11C]putrescine. (1985) (24)
Quinoline analog labeled with iodine 123 in melanoma detection. (1975) (24)
No-carrier-added aryl [18F]fluorides via the nucleophilic aromatic substitution of electron rich aromatic rings. (1990) (24)
Nucleophilic aromatic substitution; kinetics of fluorine-18 substitution reactions in polyfluorobenzenes. Isotopic exchange between 18F− and polyfluorobenzenes in dimethylsulfoxide. A kinetic study (1982) (24)
Metabolic studies of drugs of abuse. (1990) (24)
Photolysis and thermolysis of pentaphenylantimony in benzene (1969) (23)
Direct analysis of Kryptofix 2.2.2 in 18FDG by gas chromatography using a nitrogen-selective detector. (1993) (23)
The biodistribution and metabolic fate of [11C]acrylic acid in the rat after acute inhalation exposure or stomach intubation. (1982) (23)
CYCLOTRON ISOTOPES AND RADIOPHARMACEUTICALS—XXVII. 73Se (1978) (23)
18F-2-FLUORO-2-DEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY OF HUMAN CEREBRAL GLIOMAS (1981) (22)
The Spectral Signature Method for the Analysis of PET Brain Images (1991) (22)
The preparation of cyanide- 11 C for use in the synthesis of organic radiopharmaceuticals II. (1971) (22)
18F-5-Fluorouridine, a new probe for measuring the proliferation of tissue in vivo. (1982) (22)
The 122 Te( 4 He,3n) 123 Xe ( +,EC-2.1 hr) 123 I generator. (1972) (22)
Cyclotron isotopes and radiopharmaceuticals--XXVIII. Production of potassium-38 for myocardial perfusion studies. (1978) (22)
Radiopharmaceuticals. 16. Halogenated dopamine analogs. Synthesis and radiolabeling of 6-iododopamine and tissue distribution studies in animals. (1976) (22)
On-line production of 13N-nitrogen gas from a solid enriched 13C-target and its application to 13N-ammonia synthesis using microwave radiation (1983) (22)
Synthesis and evaluation of fluorinated derivatives of fentanyl as candidates for opiate receptor studies using positron emission tomograpry (1986) (22)
Stereochemical inhibition of intramolecular 1,2 shifts. Mechanistic evidence for skeletal rearrangement during apparent 1,2-methyl shifts of adamantane (1970) (21)
H18F + Sb2O3: a new selective radiofluorinating agent (1986) (21)
Comparison of two PET radioligands for imaging extrastriatal dopamine receptorsin the human brain (1993) (20)
Direct synthesis of oxygen‐15 labelled water at high specific activities (1978) (20)
Glucose metabolic changes in nontumoral brain tissue of patients with brain tumor following radiotherapy: a preliminary study. (1996) (20)
Synthesis of N‐(α,α,α‐tri[18F]fluoro‐m‐tolyl)piperazine. A potent serotonin agonist (1990) (20)
The reactivity of thermal carbon atoms in the gas phase (1968) (20)
The Metabolic Centroid Method for PET Brain Image Analysis (1989) (20)
Diminished cerebral metabolic response to motor stimulation in schizophrenics: a PET study (2005) (20)
Synthesis of 4‐fluoro‐2, 3‐dimethyl‐1‐phenyl‐3‐pyrazoline‐5‐one (4‐fluoroantipyrine) and 18f‐labeled analog by direct fluorination of antipyrine with molecular fluorine (1981) (19)
Production of High Purity lodine-123 from Xenon-124 at Energies Between 15 and 34 MeV (1987) (19)
Synthesis and preliminary evaluation in animals of carrier-free 11C-1-dopamine hydrochloride: X. (1973) (19)
Reactions of Energetic Carbon Atoms with Ammonia. II1,2 (1965) (19)
Production of carrier-free H11CN for medical use and radiopharmaceutical syntheses. IX. (1973) (19)
THE REACTIONS OF ENERGETIC CARBON ATOMS IN METHANE; OXYGEN AND PHASE DEPENDENCE; RADIATION DAMAGE EFFECTS1 (1963) (18)
Krypton-81m: a better radiopharmaceutical for assessment of regional lung function in children. (1979) (18)
A comparison of the brain uptake of N-(cyclopropyl[11C]methyl)norbuprenorphine ([11C]buprenorphine) and N-(cyclopropyl[11C]methyl)nordiprenorphine ([11C]diprenorphine) in baboon using PET. (1991) (18)
THE REACTIONS OF ENERGETIC TRITIUM AND CARBON ATOMS WITH ORGANIC COMPOUNDS (1964) (18)
Fluorine-18-N-methylspiroperidol: radiolytic decomposition as a consequence of high specific activity and high dose levels. (1987) (18)
Excitation Function for 15O Production via the 14N(d,n)15O Reaction (1977) (18)
Synthesis of L-[5-11C]ornithine. (1989) (18)
Radioisotope scintigraphy for the study of dynamics of amine regulation by the human lung. (1977) (18)
Cyclotrons, radionuclides, precursors, and demands for routine versus research compounds (1984) (17)
Cyclotron isotopes and radiopharmaceuticals XXXI. Improvements in77Br production and radiochemical separation from enriched78Se+ (1979) (17)
Bond Energy Effects and Acetylene Production in the Reactions of Energetic Carbon Atoms with Alkyl Halides and Propane1 (1966) (17)
Syntheses of 5′‐deoxy‐5‐[18F] fluorouridine and related compounds as probes for measuring tissue proliferation in vivo (1984) (17)
A direct comparison of the brain uptake and plasma clearance of N-[11C]methylspiroperidol and [18F]N-methylspiroperidol in baboon using PET. (1986) (17)
Photolysis of Carbon-2-14C1-Suboxide in Ethylene (1962) (17)
Kit for Carrier-Free 123I-Sodium Iodide. VIII (1973) (17)
Excitation Function for the 14N (p, α)11C Reaction up to 15 MeV (1978) (17)
High-resolution circular ring positron tomograph with dichotomic sampling: Dichotom-I (1983) (17)
Radiopharmaceuticals. XIX. 11C-labeled octylamine, a potential diagnostic agent for lung structure and function. (1976) (17)
A simple one-pot synthesis of cyclopropane [11C]carbonyl chloride. Synthesis and biodistribution of [11C]cyclorphan† (1986) (16)
Cyclotron and short-lived halogen isotopes for radiopharmaceutical applications (1973) (16)
A new synthesis of 2-deoxy-d-arabino-hexose (1979) (16)
Gas Phase Reactions of Recoil Carbon-14 in Anhydrous Ammonia1a (1960) (16)
Rate constants for the reactions of atomic chlorine with Group 4 and Group 5 hydrides (1978) (16)
Cross-Section Measurements for the 13C(p,n)13N and 12C(d,n)13N Nuclear Reactions (1991) (16)
Long‐lasting inhibition of in vivo cocaine binding to dopamine transporters by 3β‐(4‐Iodophenyl)Tropane‐2‐Carboxylic acid Methyl Ester: RTI‐55 or βCIT (1995) (16)
Deuterium Micromapping of Biological Samples by Using the D(T,n)4He Reaction and Plastic Track Detectors (1974) (16)
Time-dependent effects of a haloperidol challenge on energy metabolism in the normal human brain (1996) (16)
A rapid synthesis of nitrogen‐13 labelled amphetamine (1981) (16)
Detection of ocular melanoma with 4-(3-dimethylaminopropylamino)-7-[123I]-iodoquinoline. (1984) (16)
Mechanism of the Formation of Benzylacetophenone and Methylethylphenylphosphine from Methylethylphenylbenzylidenephosphorane and Styrene Oxide (1962) (15)
A diagnostic study of proton-beam irradiated water targets. (1989) (15)
A novel 123I-labeling reagent. XIII. Synthesis and loading-dose effects of 123I-iodophenylalanine and 123I-5- and6-iodotryptophan. (1974) (15)
Cyclotron isotopes and radiopharmaceuticals XXVI. A carrier-free separation of77Br from se (1978) (15)
Phase Dependence of Carbon-11 Recoil Products in Ethane and Propane; Evidence for Methylene Insertion (1963) (15)
Effect of reserpine on regional cerebral glucose metabolism in control and migraine subjects. (1986) (15)
The biosynthesis of nicotine from nicotinic acid: chemical and radiochemical yields. (1960) (14)
Cyclotron production of 123Xe and high purity 123I: A comparison of tellurium targets (1975) (14)
Tracer studies of the condensation of a Reissert compound with 1,1-diphenylethylene (1967) (14)
Application of positron emission tomography in the heart. Council on Scientific Affairs. Report of the Positron Emission Tomography Panel. (1988) (14)
ADDITION OF FLUORINE TO TOLANES (1984) (14)
The Early Detection of Brain Pathology in Alzheimer’s Disease (1992) (14)
Cyclotrons and Radiopharmaceuticals in Positron Emission Tomography (1988) (14)
Positron emission tomography. Biomedical research and clinical application. (1995) (14)
Chemical Effects of the Nuclear Transformation, C12(n,2n)C11, in Benzene: Influence of Phase Temperature and Radical Scavengers (1958) (14)
Haloperidol blocks the uptake of [18F]N‐methylspiroperidol by extrastriatal dopamine receptors in schizophrenic patients (1995) (14)
Modular automation in PET tracer manufacturing: application of an autosynthesizer to the production of 2-deoxy-2-[18F]fluoro-D-glucose. (1986) (13)
Is [1-11C]putrescine useful as a brain tumor marker? (1992) (13)
Rapid, regiospecific syntheses of deuterium substituted 6‐[18F]fluorodopamine (α,α‐D2; β,β‐D2 and α,α,β,β‐D4) for mechanistic studies with positron emission tomography (1993) (13)
Cyclotron isotopes and radiopharmaceuticals--XXIX. 81,82mRb for positron emission tomography. (1980) (13)
Quality control of radiopharmaceuticals. XIV. Sodium 123I-iodide. (1974) (13)
The synthesis of 6-deoxy-6-18F-α-D-galactopyranose (XXII)† (1977) (13)
Regiospecific radiofluorination of arylpentafluorosilicates as a general route to 18F-labelled aryl fluorides (1984) (13)
Evaluation of radiorespirometry for the determination of monoamine oxidase activity in vivo utilizing [11C]octylamine as a substrate. (1977) (13)
PET studies in the primate brain and biodistribution in mice using (-)-5'-18F-delta 8-THC. (1991) (13)
Elevated Cerebellar Glucose Metabolism in Microvascular White Matter Disease: Normal Aging and Alzheimer's Disease (1988) (12)
National Cancer Institute workshop statement: Advances in clinical imaging using positron emission tomography, September 14-16, 1988 (1990) (12)
METABOLIC MAPPING OF FUNCTIONAL CEREBRAL ACTIVITY IN MAN USING THE 18F-2-FLUORO-2-DEOXYGLUCOSE TECHNIQUE (1978) (12)
Positron emission tomography of hydrocephalus. Metabolic effects of shunt procedures. (1986) (12)
Comments on “the radionuclidic purity and quality of iodine-123 obtainable with the 124Te (p, 2n) 123I reaction” (1978) (12)
The Acid-catalyzed Rearrangement of Cinenic Acid. V. Evidence for a Decarbonylation-Recarbonylation Mechanism (1960) (12)
Inherent Errors and Lower Limit of Activity Detection in Gas-Phase Proportional Counting of Carbon-14 (1955) (12)
The Chemical Consequences of the N14(n,p)C14 Reaction in the Acetamide System and the Implications of Nuclear Recoil as a Tool for Synthesis1 (1957) (12)
Therapeutic applications of Auger and alpha emitting radionuclides. (1984) (12)
Reactions of Energetic Carbon Atoms with Nitrogen Molecules [1] (1966) (12)
The Effect of Radiation on the Reactions of Recoil Carbon -II In Ammonia (1962) (12)
States of atomic carbon produced in decomposition of organic compounds in a microwave plasma (1971) (12)
The Reactions of Cyclopropylcarbinyl Carbene Produced Photolytically in the Gas Phase1 (1966) (12)
Radioactive Anthracene-C14and Acridine-C14from the Neutron Irradiation of Acridine1 (1955) (12)
No-carrier-added N-(3-[18F]fluoropropyl)spiroperidol: biodistribution in mice and tomographic studies in a baboon. (1987) (11)
ELECTRON IMPACT DISSOCIATION OF CAMPHENE-8-C$sup 1$$sup 3$ (1958) (11)
Investigations of acetonitrile solvent cluster formation in supercritical carbon dioxide, and its impact on microscale syntheses of carbon-11-labeled radiotracers for PET. (1999) (11)
Rate constant determination of the reaction of metastable atomic nitrogen(2D,2P) with nitrogen dioxide using moderated nuclear recoil atoms (1986) (11)
Biodistribution and excretion of [11C]benzaldehyde by the rat after two-minute inhalation exposures. (1980) (11)
Serotonin 5-HT2 receptor availability in chronic cocaine abusers. (1995) (11)
Factors affecting the purity of 2-deoxy-2-fluoro-D-glucose synthesized from the reactions of glycals with acetyl hypofluorite (1986) (11)
Evidence for Walden inversion in high energy chlorine-for-chlorine substitution reactions (1979) (10)
A novel surface for high specific activity tritium labelling using microwave discharge activation of tritium gas (1978) (10)
[18F]haloperidol binding in baboon brain in vivo. (1996) (10)
Synthesis of radiopharmaceuticals and labeled compounds utilizing short- lived isotopes (1972) (10)
The Disproportionation of Ethylbenzene-1-C114under the Influence of Aluminum Bromide and Hydrogen Bromide1 (1962) (10)
Chapter 28. New Directions in Positron Emission Tomography-Part II (1990) (10)
No-carrier-added (NCA) N-(3-[18F]fluoropropyl)-N-norbuprenorphine and N-(3-[18F]fluoropropyl)-N-nordiprenorphine--synthesis, anatomical distribution in mice and rats, and tomographic studies in a baboon. (1990) (10)
Cyclotron isotopes and radiopharmaceuticals—XXIV. Titanium-45☆ (1978) (10)
Oxygen content of selected coals as determined by charged particle activation analysis (1979) (10)
Production of H18F by Deuteron Irradiation of a Neon-Hydrogen Gas Target (1983) (9)
Positron-Emission Tomography in Schizophrenia Research (1991) (9)
Use of positron emission tomography to study cocaine in the human brain. (1991) (9)
An improved synthesis of the inert, diffusible blood-flow tracer, [18F]fluoromethane. (1991) (9)
A cryogenic solid target for the production of [18F]fluoride from enriched [18O]carbon dioxide (1993) (9)
Selectivity in catalytic alkyne cyclotrimerization over chromium(VI): kinetic evaluation using the characteristics of radioactive carbon-11 decay for nondisruptive ultrasensitive detection of adsorbed species (1984) (9)
INVESTIGATION OF SYNTHESIS VERSUS REËNTRY IN TWO ORGANIC NITROGEN CONTAINING SYSTEMS UNDER NEUTRON IRRADIATION1 (1956) (9)
Syntheses and specific activity determinations of no-carrier-added (NCA) F-18-labeled butyrophenone neuroleptics--benperidol, haloperidol, spiroperidol, and pipamperone. (1985) (9)
Yield measurements for the 11B(p,n)11C and the 10B(d,n)11C nuclear reactions. (1998) (9)
Determination of the enantiomeric composition of samples of cocaine by normal-phase high-performance liquid chromatography with UV detection. (1992) (9)
Syntheses of astato compounds by melt method (1981) (8)
Chemical effects following 14N(n,p)14C in magnesium nitride (1969) (8)
Process signals to control radiotracer syntheses: Experience with the automated production of 2-deoxy-2-[18F]fluoro-D-glucose (1989) (8)
ANHYDROUS 18F LABELED ELEMENTAL FLUORINE FOR RADIOPHARMACEUTICAL PREPARATION (1981) (8)
Ethylene formation in carbon atom reactions. Mechanism and isotope effects (1975) (8)
ABSOLUTE CROSS SECTIONS FOR THE PRODUCTION OF 18F VIA THE 18O(p,n) 18F REACTION (1980) (8)
Cyclotron production of lead-203 for radiopharmaceutical applications☆☆☆ (1973) (8)
Mechanistic pet studies demonstration of a deuterium isotope effect in the mao catalyzed binding of carbon 11 l deprenyl in living baboon brain (1987) (8)
The utility of 1-[18F]fluoro-3-iodopropane for the synthesis of certain dopamine D-1 and benzodiazepine receptor radioligands. (1990) (8)
Abnormal temporal lobe response in Alzheimerʼs disease during cognitive processing as measured by 11C-2-deoxy-D-glucose and PET (1987) (8)
The formation of carbon atoms in the decomposition of a carbene (1970) (8)
FORMATION OF EXCITED INTERMEDIATES IN RECOIL CARBON ATOM REACTIONS. PRESSURE-DEPENDENCE STUDIES IN THE GAS PHASE. (1969) (8)
Remote processing, delivery and injection of H2[15O] produced from a N2/H2 gas target using a simple and compact apparatus. (1994) (8)
Production and use of cobalt-55 as an antibody label for PET imaging (1994) (8)
Stereochemical consequences of hydrogen exchange as a result of tritium atom reactions on solid aliphatic amino acids. (1977) (8)
Evaluation of Regional Glucose Metabolism with Positron Emission Tomography in Normal and Psychiatric Populations (1983) (8)
Synthesis and binding to striatal membranes of no carrier added I‐123 labeled 4′‐iodococaine. (1992) (7)
Positron emission tomography study of human prostatic adenocarcinoma using carbon-11 putrescine. (1994) (7)
The heritage of radiotracers for positron emission tomography. (1990) (7)
The Rearrangement and Condensation of Reissert Compounds with Grignard Reagents1 (1956) (7)
Organic radiopharmaceuticals: recent advances (1979) (7)
Distribution of various labeled thioglucoses in rodents. (1975) (7)
Stereochemical consequences of bromine-for-halogen substitutions in the gas phase (1983) (7)
Cyclotron Isotopes and Radiopharmaceuticals. (1986) (7)
Mechanism of nitrogen-13-labeled ammonia formation in a cryogenic water target. (1999) (7)
A comparative study of the preparation of radioactive 4‐bromoantipyrine and 4‐iodoantipyrine for the measurement of cerebral blood flow (1983) (7)
Production of Iodine-123 from Xenon-124: Cross-Section and Yields (1992) (7)
Reactions of recoiling carbon-11 atoms with toluene (1986) (7)
Improvements in the production of [18F]N‐methylspiroperidol and [18F]haloperidol (1989) (6)
Synthesis of 3H- and 14C-labeled tracers for studies of functional monoamine oxidase activity (1988) (6)
Mechanism of the thermal decomposition of the condensation product of a phosphonium ylide with an epoxide (1967) (6)
Computed Tomography and Positron Emission Transaxial Tomography Evaluations of Normal Aging and (1983) (6)
Stereochemical consequences of thermal fluorine-for-chlorine atomic substitution with 2(S)-(+)-chloropropionyl chloride (1987) (5)
Instrumentation in Positron Emission Tomography (1988) (5)
EFFECT OF RADIATION ON THE REACTIONS OF RECOIL $sup 11$C IN PERFLUOROCARBON- -OXYGEN SYSTEMS. (1970) (5)
Reaction of tritium atoms with unsaturated compounds (1977) (5)
Note on the distribution of iodine-123-labeled indocyanine green in the eye. XVIII. (1975) (5)
Decarbonylation of aroyl fluorides using Wilkinson's catalyst: a reevaluation (1982) (5)
The Production of Radionuclides 123I, 77Br for Nuclear Medicine with High Energetic 4He Particles (1975) (5)
Reactions with aromatic compounds of recoiling bromine atoms formed from the /sup 76/ /sup 77/Kr. -->. /sup 76/ /sup 77/Br transformations. Liquid-phase reactions (1983) (5)
A study of proton beam penetration in a small-volume water target (1989) (5)
Gas-phase reactions involving hot oxygen-18 18O(3P) atoms and formaldehyde (1992) (5)
Cyclotron Isotopes and Radiopharmaceuticals (1985) (5)
Photolysis of carbon suboxide in 1,2-dimethylcyclopropene (1966) (5)
The evaluation of the lumped constant for deoxyglucose and fluorodeoxyglucose in man (1984) (5)
An Automatic GLPC Apparatus for the Analysis of Organic Compounds Labeled with Short-Lived Radioisotopes (1969) (5)
Cyclotron isotopes and radiopharmaceuticals--XXXIII. Synthesis and structural effect of selective biliary excretion of halogenated indotricarbocyanines. (1983) (5)
Benzene-14C1 from the Neutron Irradiation of the Clathrate with Ammoniacal Nickel Cyanide (1955) (5)
High energy alpha reactions for the production of the generator and 125Xe and 127Cs for radiopharmacuetical applications (1976) (5)
Alcohol intoxication does not change [11C]cocaine pharmacokinetics in human brain and heart. (1992) (5)
Simultaneous Electroencephalogram Mapping and Positron Emission Tomography in Chronic Schizophrenia: Preliminary Results in Neuroleptic Treated Patients (1993) (4)
PRODUCTION AND REACTIVITY OF $sup 11$C IN SOLID COMPOUNDS. (1969) (4)
The CO2/CO Ratio as Internal Radiation Dosimeter in Recoil Carbon Atom Studies (1968) (4)
Synthesis of 5‐deuteromethyl‐2′‐deoxyuridine (thymidine‐α,α,α‐d3) and related compounds (1980) (4)
PET-deoxyglucose, CT, and neuropathology of age-related white matter pathology in normals and Alzheimer's patients (1989) (4)
Localization of radioactive lead in ocular and skin melanoma. (1975) (4)
Radioactive phosphorus uptake test. An in vitro analysis of choroidal melanoma and ocular tissues. (1980) (4)
Reactions of energetic carbon-11 in homologous gas-phase halocarbons (1984) (4)
Tissue distributions of radiopharmaceuticals labeled with positron emitters and problems in relating them to human studies (1983) (4)
Carbon-14 Recoil in Azobenzene-Stilbene Solid Solutions1a (1960) (4)
CYCLOTRON ISOTOPES AND RADIOPHARMACEUTICALS—XXVIII. PRODUCTION OF POTASSIUM‐38 FOR MYOCARDIAL PERFUSION STUDIES (1979) (4)
Effect of foil material on the apparent yield of the 124Xe(p, x)123I reaction. (1992) (4)
Kinetic evaluation of propyne surface diffusivity on silica-alumina-supported chromium(VI) using positron annihilation surface detection (1984) (4)
Rapid catalytic synthesis of 11C-labelled aromatics (1982) (4)
Mechanisms and Isotope Effects in the Reactions of Energetic Carbon Atoms with Hydrocarbons and Alkylfluorides (1969) (4)
Synthesis of 2-deoxy-D-(1-/sup 11/C)glucose for regional metabolic studies: concise communication (1981) (3)
Reaction selectivity of translationally and electronically excited carbon-11 atoms with ethylene (1983) (3)
RADIOPHARMACEUTICALS PART 12, A NEW RAPID SYNTHESIS OF CARBON-11 LABELED NOREPINEPHRINE HYDROCHLORIDE (1974) (3)
Tritium distribution, enantiomer formation, and glycine production in L‐valine labeled by microwave discharge activation of tritium gas (1977) (3)
CYCLOTRON ISOTOPES AND RADIOPHARMACEUTICALS—XXIII. NOVEL ANHYDROUS 18F-FLUORINATING INTERMEDIATES (1979) (3)
Zone refining for the separation of radioactive trace contaminants from organic compounds (1968) (3)
The Mechanism of the Disproportionation of Ethylbenzene1,2 (1966) (3)
Photolysis of diazo-n-butane. Study of the unimolecular decomposition of activated intermediates and energy partitioning (1975) (3)
Stereochemical consequences of halogen atom substitution. 1. Rotational conformer effects in gaseous diastereomeric 2,3-dihalobutanes (1990) (3)
Preparation of ring‐labelled adamantane derivatives. I. 2‐adamantanecarboxylic acid‐2‐14C and 2‐methyladamantane‐2‐14C (1970) (3)
The Effect of Rare Gas Additives on the Reactions of Carbon-11 Atoms Following 12C(p,pn)11C in Saturated Hydrocarbon Systems (1972) (3)
Evidence for carbon-11 stripping and abstraction reactions leading to acetylene formation (1970) (3)
No-carrier-added (NCA) (+/-)-N-(3-[18F]fluoropropyl)-N-normetazocine-synthesis and PET studies in a baboon. (1987) (3)
Carbon‐11 labeled (±)‐ and (‐)‐ketamine: Synthesis and PET studies in a baboon (1989) (3)
On the possibility of phenyl group migration in 7-phenyl-1,3,5-cycloheptatriene (1969) (3)
Regional glucose metabolism in chronic schizophrenia. (1988) (3)
Preparation of multitritiated arenes (1982) (3)
Recoil labeling and selective radiation labeling a novel synthesis of propanol‐2,3‐14C1 (1968) (3)
The Formation of Bitropyl in the Radiolysis of Carbon-14 Labeled Cycloheptatriene1 (1961) (3)
Transient toxicity of 2-deoxy-2-[18F]fluoro-D-glucose in mammalian cells: concise communication. (1983) (3)
Additions and Corrections - On the Probable Intermediacy of Tetrahedrane (1970) (2)
Accelerators for Positron Emission Tomography (1993) (2)
The Reactions with Benzene of Recoiling Bromine Atoms Formed from the 76,77Kr→ 76,77Br Transformations. Effects of Phase and Non-Inert Chemical Additives [1a] (1984) (2)
Ethylene (carbon-11) formation in alkyl chlorides. Mechanisms and isotope effects (1978) (2)
Labeled Compounds for Positron Emission Tomography (1983) (2)
Carrier-free $sup 11$C-labeled catecholamines in nuclear medicine and biochemical research (1973) (2)
The test-retest PETT experiment paradigm: The subject as his own reference (1984) (2)
Synthesis and biodistribution of 2-deoxy-2-[18F]fluoro-d-glucopyranosyl [18F]fluoride in mice (2004) (2)
Evidence for the electronic states of recoil carbon atoms undergoing reaction (1976) (2)
New developments in radiotracers for positron emission tomography. (1991) (2)
18F-to-Halogen Exchange Reaction on α,α,α-Trihalotoluenes. A Useful Route to No-Carrier-Added (NCA) 18FLabeled Substitutedα,α,α-Trifluorotoluenes (1990) (2)
CT, MRI, and PET Studies of Hippocampal Pathology in Alzheimer’s Disease (1992) (2)
Reactions involving hot oxygen (3P) atoms and isomeric 2-butene (1992) (2)
A sputtering derived atomic oxygen source for studying fast atom reactions (1987) (2)
PREPARATION OF ORGANIC RADIOPHARMACEUTICALS CONTAINING ISOTOPES OF SHORT HALF-LIFE. (1971) (2)
Medical autoradiography with stable isotope thymidine: theory and preliminary experiments (1973) (2)
Target design considerations for high specific activity [{sup 11}C]O{sub 2} (1993) (2)
Recent advances in the chemistry of positron emitters (1985) (2)
Probing the biochemical basis of the PET image. Mechanistic PET studies of [11C]L-deprenyl binding using the deuterium isotope effect (1989) (2)
A flow method for the study of silicon and germanium atom reactions by direct spectroscopic observation (1971) (2)
$sup 123$I-indocyanine green ($sup 123$I-ICG) as an agent for dynamic studies of the hepato biliary system (1974) (2)
The degenerate isomerization of adamantane (1970) (2)
Factors influencing reactivity of thermal H(T) atoms with solids. I. Physical effects (1985) (2)
Quantitation Of The Human Basal Ganglia with Positron Emission Tomography (1990) (2)
New improved synthesis of 2-deoxy-2-(/sup 18/F)fluoro-d-glucose from /sup 18/F-labeled acetyl hypofluorite (1982) (2)
REACTIONS WITH AROMATIC COMPOUNDS OF RECOILING BROMINE ATOMS FORMED FROM THE KRYPTON-76,77 → BROMINE-76,77 TRANSFORMATIONS. LIQUID-PHASE REACTIONS (1983) (2)
Evidence for the selective addition of thermal 11C(1D) atoms to Carbon–Carbon double bonds (1982) (2)
CYCLOTRON ISOTOPES AND RADIOPHARMACEUTICALS—XXV. AN ANHYDROUS 18F‐FLUORINATING INTERMEDIATE: TRIFLUOROMETHYL HYPOFLUORITE (1979) (2)
Small cyclotrons and the production of positron emitters: present and future (1984) (2)
Tritium labeling of amino acids in polypeptide hormones. (1975) (2)
125I-β-iodo-D-alanine-synthesis, biodistribution and antimicrobial activity (2004) (1)
DIRECT SYNTHESIS OF OXYGEN-15 LABELED WATER AT HIGH SPECIFIC ACTIVITIES (1979) (1)
PET‐DEOXYGLUCOSE, CT AND NEUROPATHOLOGY STUDIES OF AGE RELATED WHITE MATTER PATHOLOGY IN NORMALS AND ALZHEIMER DISEASE (1988) (1)
Study of Coal Oxidation by Charged Particle Activation Analysis (1980) (1)
Determination of glucose metabolism of brain tumors and adjacent normal brain tissue and their early response to radiotherapy by f-18 fluorodeoxglulose position emission tomography (FDG-pet scan) (1994) (1)
Short-lived radiopharmaceuticals for the diagnosis of ocular melanoma (1974) (1)
Recent developments and new approaches at the cyclotron for the preparation of short-lived nuclides for radiopharmaceuticals (1973) (1)
Cyclotron isotopes and radiopharmaceuticals— XXI. Fabrication of 122TeAu targets for isotope production☆ (1977) (1)
Ethylene-11C Formation in Hydrogen-Alkane and Hydrogen-Alkylhalide Mixtures [1] (1975) (1)
Cyclotrons and Positron Emitting Radiopharmaceuticals (1987) (1)
A comparison of (/sup 18/F)spiroperidol, (/sup 18/F)benperidol and (/sup 18/F) haloperidol kinetics in baboon brain (1984) (1)
Synthesis of 2-deoxy-2[82Br]bromo-d-mannose and related compounds and their biodistributions in mice (2004) (1)
Structural Influences on the Chemical Reactivity of Hydrocarbons Toward Nucleogenic Carbon Atoms (1997) (1)
Implication of functional imaging studies of neurotransmitter interactions in the living brain (1997) (1)
Inexpensive equipment for studying the irradiation of organic materials under static conditions using a reactor or gamma source. (1958) (1)
Stereochemical Consequences of Thermal Fluorine-for-Chlorine Atomic Substitution with 2(S)-(+)-Chloropropionyl Chloride. (1987) (1)
CEREBRAL FUNCTIONAL ACTIVITY MAPPED WITH 18F-2-DEOXY-2-FLUORO-D-GLUCOSE (1982) (1)
A tracer study of the acid-catalyzed condensation of 2-benzoyl-1,2-dihydroisoquinaldonitrile with 1,1-diphenylethylene (1965) (1)
Distributed Microprocessor Automation Network for Synthesizing Radiotracers Used in Positron Emission Tomography (1987) (1)
Synthesis of 11C-compounds including double isotopic labelling: Some perspectives (1988) (1)
Non-invasive nuclear detection of choroidal melanoma (1981) (1)
Short-lived positron emitter labeled radiotracers - present status (1982) (1)
The value of "the putrescine experience". (1992) (1)
Special characteristics and potential for radiotracers for positron emission tomography. (1981) (1)
Rapid radiochemical and chemical quality control of [11C]putrescine. (1993) (1)
Preparation of ring labelled adamantane derivatives II. 2‐adamantanone‐2−14C, adamantane‐2−14C and 1‐methyladamantane‐2 or 4−14C (1971) (1)
Distribution of radioactivity in recoil‐labelled toluene‐14C (2010) (1)
Radiation dosimetry of 2 (/sup 18/F)fluoro-2-deoxy-D-glucose in man (1982) (1)
The disproportionation of ethylbenzene-1-C141 under the influence of aluminum bromide and hydrogen bromide (1961) (1)
The biodistribution and metabolic fate of inhaled 11C-octanal in the rat after acute exposure. (1981) (1)
Use of recoiling carbon-14 as a new technique in labeling organic compounds (1957) (1)
GABAERGIC MODULATION OF ENDOGENOUS NEUROTRANSMITTER RELEASE MEASURED IN VIVO WITH POSITRON EMISSION TOMOGRAPHY. (1992) (1)
High-resolution circular ring positron tomograph with dichotomic sampling: Dichotom-I. (1984) (1)
PET in drug research and development (1992) (1)
Evidence for the reaction of a long-lived monotypic species of iodine in the gas phase (1981) (1)
An Inexpensive Automated Recycle Radiogas Chromatograph (1976) (1)
Synthesis of (/sup 18/F)-5-fluorouridine (F-18-5-FUR) as a probe for measuring RNA synthesis and tumor growth rates in vivo (1979) (1)
Synthesis of 131I‐Labelled β‐Iodo‐D‐alanine and related compounds (1980) (1)
Hot cell for the synthesis of labelled organic compounds (1979) (1)
Fluorine-18 chemistry and its application to positron emission tomography (1983) (1)
Reaction intermediates in the chemistry of recoil carbon atoms (1968) (1)
The reactions of trans-2,3-dimethylcyclopropyl methylene produced photolytically in the gas phase (1969) (1)
Comparative evaluation of $sup 123$I and /sup 99m/Tc for thyroid studies (1973) (0)
125I-beta-iodo-D-alanine-synthesis, biodistribution and antimicrobial activity. (1981) (0)
Use of the PETT III at brookhaven in metabolic and imaging studies with 18F-fluorodeoxyglucose and other compounds (1978) (0)
Pet studies of monoamine oxidase B (MAO B) (1992) (0)
No-carrier-added [18 F]-N-fluoroalkylspiroperidols (1990) (0)
Analytical Control of Radiopharmaceuticals Section CYCLOTRON ISOTOPES AND RADIOPHARMACEUTICALS* xxvI. A CARRIER-FREE SEPARATION OF ~ ~Br FROM Se (1978) (0)
PET Studies of Cocaine in Human Brain (2020) (0)
Applied hot-atom chemistry, labeling of compounds, isotope production (1974) (0)
Contents of the American Journal of Psychiatry (1993) (0)
PRELIMINARY NOTES Detection of Ocular Melanoma with 4-(3-Dimethylaminopropylamino)-7-[123l]- lodoquinoline (2006) (0)
A simple system for remote processing and delivery of H{sub 2}[{sup 15}O] produced from a N{sub 2}/H{sub 2} target (1993) (0)
RADIOPHARMACEUTICALS. 16. HALOGENATED DOPAMINE ANALOGS. SYNTHESIS AND RADIOLABELING OF 6-IODODOPAMINE AND TISSUE DISTRIBUTION STUDIES IN ANIMALS (1976) (0)
Determination of the lumped constant and the kinetic constants for deoxyglucose and fluorodeoxyglucose in man (1985) (0)
Effect of Translational Energy on the Reactions Involving Excited N(2D) and Cl2 (1997) (0)
INEXPENSIVE EQUIPMENT FOR STUDYING THE IRRADIATION OF ORGANIC MATERIALS IN A PILE UNDER STATE CONDITIONS (1956) (0)
The yield of F-18 from different target designs in the {sup 18}O(p,n){sup 18}F reaction on frozen [{sup 18}O]CO{sub 2} (1993) (0)
NEUTRON IRRADIATION OF BENZENE AND OF TOLUENE IN 2-METHYLPYRAZINE. AN INVESTIGATION OF SYNTHESIS VERSUS RE-ENTRY (1957) (0)
REACTIONS OF ENERGETIC $sup 11$C-ATOMS IN FLUOROHYDROCARBON SYSTEMS. (1968) (0)
Production of carrier-free H.sup.11 CN (1978) (0)
of Human Brain MA 0 B After L-Deprenyl ( Selegeline ) Withdrawal (2004) (0)
Summary of discussion: Models and technology used in positron emission tomography (1984) (0)
Kit for carrier-free 123 I-sodium iodide. 8. (1973) (0)
No-carrier-added [111 c]putrescine (1990) (0)
A routine production system for F-18 from frozen oxygen-18 enriched carbon dioxide (1994) (0)
In Vivo Measurement of Transport and Metabolic Processes Using Radiotracers * (2021) (0)
PETT: quantitative in vivo measurement of human function and metabolism (1981) (0)
Hot cell for synthesis of labeled organic compounds (1979) (0)
A dual-reservoir remote loading water target system for {sup 18}F and {sup 13}N production with direct in-target liquid level sensing (1991) (0)
Electron density and bond polarization effects in reactions of energetic carbon-11 leading to acetylene (1984) (0)
AnhydrousF-18 LabeledElementalFluorinefor Radiopharmaceutical Preparation (1980) (0)
Plasma protein binding as a determinant of brain extraction—radiohalogenated cocaines (1992) (0)
Syntheses of (/sup 18/F) aryl fluorides by fluorination of aryltrimethylsilanes or arylpentafluorosilicates with (/sup 18/F)F/sub 2/ or (/sup 18/F)CH/sub 3/CO/sub 2/F (1984) (0)
Cyclotrons for clinical and biomedical research with PET (1987) (0)
Stereochemical consequences of halogen atom substitution. 3. Recoil [sup 18]F-for-X (X = F, Cl) reactions in gaseous diastereomeric 2,3-dihalobutanes (1993) (0)
Reactions of energetic carbon-11 with benzene leading to acetylene (1987) (0)
Robotics at a Biomedical Cyclotron Facility (1984) (0)
Effect of target-gas purity on the chemical form of F-18 during /sup 18/F-F/sub 2/ production using the neon/fluorine target (1980) (0)
Is [l-nC]Putrescine Useful as a Brain Tumor Marker? (2006) (0)
Neuroimaging Studies of Alzheimer’s Disease (1986) (0)
POSITRON EMISSION TOMOGRAPHY (PET) AND COMPUTED TOMOGRAPHY (CT) EVALUATIONS COMBINED IN THE STUDY OF SENILE DEMENTIA OF THE ALZHEIMERʼS TYPE (1983) (0)
Hot-atom chemistry of carbon (1974) (0)
Drug pharmacokinetics and pharmacodynamics: Technological considerations (1992) (0)
Model studies using supercritical carbon dioxide fluid (SF CO{sub 2}) as a reaction medium for radiotracer synthesis and purification (1994) (0)
RADIOASSAY BY GAS CHROMATOGRAPHY-FLOW COUNTER UNIT AT ELEVATED TEMPERATURE (1963) (0)
PET studies of drugs affecting monoamine systems (1992) (0)
Synthesis and biodistribution of (C-11) labeled irreversible inhibitors of MAO A and B (1985) (0)
Radiopharmaceuticals in PET, progress and promise (1988) (0)
acute neuroleptic administration . schizophrenia before and after Brain metabolism in patients with and (2004) (0)
DECARBONYLATION OF AROYL FLUORIDES USING WILKINSON′S CATALYST: A REEVALUATION (1982) (0)
Radiotracers for PETT: new developments and perspectives (1983) (0)
COMPETITIVE GAS PHASE REACTIONS OF $sup 11$C IN BINARY OXYGEN-ALKANE SYSTEMS (1964) (0)
Hot Oxygen Atoms: Their Generation and Chemistry (1988) (0)
Local cerebral glucose utilization measured with 18F-2-fluoro-2-deoxyglucose (1978) (0)
Continuous registration of the thyroidal uptake of /sup 99m/Tc and $sup 123$I in the first 30 minutes (1973) (0)
Rapid synthesis of carrier free $sup 11$C-dopamine hydrochloride (1975) (0)
Synthesis of 4-[18F]fluoroantipyrine and its biodistribution in mice (2004) (0)
Production of radionuclides /sup 123/I, /sup 77/Br for nuclear medicine with high energetic /sup 4/He particles (1975) (0)
No-carrier-added [.sup.18 F]-N-fluoroalkylspiroperidols (1989) (0)
Quantitative Macroautoradiography for the Study of Radiopharmaceutical s with Special Reference to Positron-Emitting Compounds (1982) (0)
1-/sup 11/C-2-deoxy-D-glucose and process for the preparation thereof (1980) (0)
Analysis of PETT images in psychiatric disorders (1983) (0)
Accelerator produced nuclides for use in biology and medicine. A bibliography, 1939--1973 (1975) (0)
Synthesis of carbon-11 and fluorine-18 labeled 4-fluorodeprenyl as probes for functional monoamine oxidase. (1989) (0)
Tritium labeling of organic compounds deposited on porous structures. [DOE Patent] (1979) (0)
Use of supercritical carbon dioxide fluid as a solvent for the purification of pet radiotracers (1993) (0)
Synthesis of. cap alpha. ,. cap alpha. ,. cap alpha. -tri(/sup 18/F)fluorotoluenes (1985) (0)
Decomposition as a Consequence of High Specffic Activity and High Dose Levels (2006) (0)
The heritage of radiotracers for PET (1988) (0)
Reaction of energetic 11C(1D) atoms with ethylene by double-bond insertion (1982) (0)
Process for the production of 5'-deoxy-5-(/sup 18/F)fluorouridine (1983) (0)
Iodine-124 production: Excitation function for the [sup 124]Te(d,2n)[sup 124]I and [sup 124]Te(d,3n)[sup 123]I reactions from 7 to 24 MeV (1992) (0)
New Trends in Radiopharmaceutical Synthesis Using Positron Emitters: Quality Control (1991) (0)
Is MRI-PET coregistration required for quantification of striatal dopamine receptors? (1995) (0)
Positron Emission Tomography, Enzymes and Drug Research and Development (1993) (0)
$sup 122$Te($sup 4$He,3n)$sup 123$Xe $beta$$sup +$, EC/2.1 hr $Yields$ $sup 123$I GENERATOR. (1972) (0)
Stereochemical Consequences of Recoil Halogen Atom Substitution (1990) (0)
Mass separation due to the rapid expansion of supercritical carbon dioxide fluid across a radial thermal gradient (1995) (0)
PHASE DEPENDENCE OF CARBON-11 RECOIL PRODUCTS IN PROPANE EVIDENCE FOR METHYLENE INSERTION (1962) (0)
TRITIUM LABELING OF POLYPEPTIDE HORMONES--ADRENOCORTICOTROPIN (ACTH). (1972) (0)
THE USE OF PETT III AT BROOKHAVEN (1978) (0)
A REACTION-RADIOGAS CHROMATOGRAPH FOR ANALYSIS OF HIGH-BOILING NITROGEN- AND SULFUR-CONTAINING ORGANIC COMPOUNDS OF LOW SPECIFIC $sup 14$C- OR $sup 11$C-ACTIVITY (1964) (0)
Radiotracers in PETT: strategies for in vivo receptor activity, Schizophernia, and Alzheimer's Dementia studies (1984) (0)
Methodological issues in the pet scan evaluation of F-18 NMS binding in tardive dyskinesia (TD) (1989) (0)
.sup.18 F-4-Fluoroantipyrine (1984) (0)
THE USE OF POSITRON EMISSION TOMOGRAPHY IN IDENTIFYING AND QUANTIFYING RECEPTORS INVOLVED IN SCHIZOPHRENIA. (1991) (0)
GAS RADIOCHROMATOGRAPHY OF $sup 14$C- AND $sup 11$C-LABELED ALIPHATIC CARBOHYDRATES AND AMINES (1963) (0)
Stereo and regioselectivity in ''Activated'' tritium reactions (1988) (0)
Stereochemical Consequences of Halogen Atom Substitution. Part 1. Rotational Conformer Effects in Gaseous Diastereomeric 2,3-Dihalobutanes (1990) (0)
Author's Reply to K. J. Worsley (1990) (0)
EXCITATION FUNCTION FOR THE 14N(p,α)11C REACTION UP TO 15 MeV (1979) (0)
Astatine-211 colloid thearpy of experimental malignant ascites (1980) (0)
Stereochemical Consequences of Recoil Halogen Atom Substitution IV : Effect of Kinetic Energy Moderator Concentration on the 18F-for-X (X=Br, F) Reactions in Gaseous Diastereomeric 2,3-Bromofluorobutanes (1997) (0)
Factors affecting the purity of 2-fluoro-2-deoxy-D-glucose (2-FDG) synthesized from the reactions of glycals with acetyl hypofluorite (CH/sub 3/CO/sub 2/F) (1985) (0)
Imaging receptors and their interactions: Implications for psychiatry (1989) (0)
No-carrier-added (/sup 18/F)-N-methylspiroperidol (1985) (0)
THE USE OF THE N$sup 14$(p,/cap alpha/)C$sup 11$ REACTION IN STUDYING THE RECOIL CHEMISTRY OF CARBON (1962) (0)
Stereochemical Consequences of Halogen-for-Halogen Substitutions with Gaseous Enatiomers (1988) (0)
RADIOACTIVE ANTHRACENE-C$sup 14$ AND ACRIDINE-C$sup 14$ FROM THE NEUTRON IRRADIATION OF ACRIDINE (1954) (0)
STEREOCHEMICAL CONSEQUENCES OF HYDROGEN EXCHANGE AS A RESULT OF TRITIUM ATOM REACTIONS ON SOLID ALIPHATIC AMINO ACIDS (1977) (0)
SYNTHESIS OF C-11-COMPOUNDS INCLUDING DOUBLE ISOTOPIC LABELING - SOME PERSPECTIVES (1988) (0)
Novel $sup 123$I-labeling reagent. XIII. Synthesis and loading-dose effects of $sup 123$I-4-iodophenylalanine and $sup 123$I-5- and 6-iodotryptophan (1974) (0)
AND RADIOPHARMACEUTICALSYNTHESES.IX. (1973) (0)
Factors Affecting the Purity of 2-Deoxy-2-fluoro-D-glucose Synthesized from the Reactions of Glycals with Acetyl Hypofluorite. (1986) (0)
BIOCHEMICAL STUDIES WITH THE PET RADIOTRACER F‐18 N‐METHYLSPIROPERIDOL (NMS). (1992) (0)
Patterns of brain activity in normals and schizophrenics with positron emission tomography (1985) (0)
Production and quality control of iodine-123 (1975) (0)
Indocyanine green labeled with /sup 123/I for dynamic studies of the hepato-biliary system. [/sup 131/I, /sup 125/I] (1975) (0)
REACTIONS AND MECHANISMS INVOLVING HOT CARBON ATOMS AND N$sub 2$-H$sub 2$, N$sub 2$- ALKANE AND N$sub 2$- ALKANE-MODERATOR SYSTEMS INCLUDING THEIR RELATIONSHIP TO OTHER SIMPLE SYSTEMS (1964) (0)
in 1 8 Patients With Chronic Schizophrenia (1987) (0)
TRITIATION BY MICROWAVE DISCHARGE ACTIVATION OF TRITIUM GAS: A STUDY OF MECHANISM AND ITS APPLICATION TO THE LABELING OF ADRENOCORTICOTROPIC HORMONE (ACTH). (1972) (0)
(/sup 11/C)clorgyline and (/sup 11/C)-L-deprenyl and their use in measuring functional monoamine oxidase activity in the brain using positron emission tomography (1986) (0)
Kit for carrier-free $sup 123$I-sodium iodide. VIII (1973) (0)
Tritium and its compounds (1967) (0)
Recent Advances in Radiotracers for Pet Studies of the Brain (2021) (0)
A system for the routine production of car (2006) (0)
Rate Constant Determination of the Reaction of Metastable N(2D,2P) with NO2 Using Moderated Nuclear Recoil Atoms (1987) (0)
Hot oxygen atoms: Their generation and chemistry. [Production by sputtering; reaction with butenes] (1987) (0)
Electrophilic Radiofluorination of Aryltrimethylsilanes as a General Route to 18F-Labeled Aryl Fluorides. (1986) (0)
Regional glucose metabolism using PETT in normal and psychiatric populations (1982) (0)
A universal water target loading system with direct in-target liquid level sensing. (1992) (0)
No-carrier-added [1.sup.11 c]putrescine (1989) (0)
SYNTHESISAND PRELIMINARY EVALUATION IN ANIMALS OF (1973) (0)

This paper list is powered by the following services:

Alfred P. Wolf's Academic­Influence.com Rankings

Alfred P. Wolf's Degrees

Why Is Alfred P. Wolf Influential?

Alfred P. Wolf's Published Works

Published Works

Alfred P. Wolf's AcademicInfluence.com Rankings